The Future of Vaccinology Symposium was hosted by McMaster’s Global Nexus School for Pandemic Prevention & Response and the Michael G. DeGroote Institute for Infectious Disease Research.
The startups, HARvEST, A.I. VALI Inc. and Esphera SynBio, each received $256,000 in the third round of McMaster Seed Fund investments.
The inhaled aerosol vaccine is far more effective at inducing protective immune responses than traditional injections, targeting the lungs and upper airways where viruses first enter the body and providing long-lasting protection against respiratory infections.